Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients
NCT: NCT07630766 · COMPLETED
Brief Summary
Extubation failure is associated with increased morbidity and mortality in critically ill patients. High-risk patients may benefit from preventive respiratory support after extubation. This randomized controlled trial compared noninvasive ventilation (NIV) with high-flow nasal cannula (HFNC) in adult intensive care unit (ICU) patients at high risk of extubation failure. The study evaluated reintubation rates, time to reintubation, physiological parameters, complications, and clinical outcomes following planned extubation. The aim was to determine the optimal post-extubation respiratory support strategy for reducing extubation failure in high-risk ICU patients.
Frequently Asked Questions
What is Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients?
Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients is a clinical trial registered under NCT07630766. Current status: COMPLETED.
What is the status of NCT07630766?
The current status of NCT07630766 (Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients) is: COMPLETED.
When did Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients start?
Noninvasive Ventilation Versus High-Flow Nasal Cannula After Extubation in High-Risk ICU Patients started on 2025-07-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.